As of Jul 25
| -0.12 / -0.69%|
The 7 analysts offering 12-month price forecasts for Insmed Inc have a median target of 23.00, with a high estimate of 35.00 and a low estimate of 17.00. The median estimate represents a +33.49% increase from the last price of 17.23.
The current consensus among 8 polled investment analysts is to Buy stock in Insmed Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.